Stem Cell Therapy for Microvascular Injury Associated with Ischemic Nephropathy

Area of Science:

• Nephrology
• Regenerative Medicine
• Medical Imaging

Background:

• Ischemic nephropathy involves kidney function loss due to atherosclerosis, leading to microvascular damage, hypoxia, and inflammation.
• Functional MRI is used to assess tissue oxygenation and understand renal adaptation limits in ischemic nephropathy.
• Mesenchymal stromal/stem cells (MSC) can modulate angiogenesis and immune responses, but efficacy varies with patient factors.

Purpose of the Study:

• To review the application of functional MRI in evaluating tissue oxygenation in ischemic nephropathy.
• To summarize first-in-human studies on intrarenal infusion of adipose-derived MSC for ischemic nephropathy.
• To assess the impact of MSC therapy on renal blood flow, hypoxia, inflammation, and kidney function.

Main Methods:

• Review of functional MRI techniques for assessing renal tissue oxygenation.
• Summary of clinical data from human trials involving autologous adipose-derived MSC infusion.
• Analysis of changes in renal blood flow, tissue hypoxia, inflammatory markers, and kidney function post-MSC therapy.

Main Results:

• MSC infusion in ischemic nephropathy patients increased renal blood flow and reduced tissue hypoxia.
• A decrease in inflammatory biomarkers was observed in the renal vein after MSC infusion.
• Modest, dose-related improvements in kidney function were associated with MSC therapy.

Conclusions:

• Autologous adipose-derived MSC show potential in partially repairing microvascular injury in ischemic nephropathy.
• MSC therapy may play a role in addressing tissue hypoxia and improving kidney function in this condition.
• Further research is warranted to optimize MSC therapy for ischemic nephropathy.